Circulation, Vol 88, 416-429, Copyright © 1993 by American Heart Association
A Volpi, C De Vita, MG Franzosi, E Geraci, AP Maggioni, F Mauri, E Negri, E Santoro, L Tavazzi and G Tognoni
BACKGROUND. Current knowledge of risk assessment in survivors of myocardial
infarction is largely based on data gathered before the advent of
thrombolysis. It must be determined whether and to what extent available
information and proposed criteria of prognostication are applicable in the
thrombolytic era. METHODS AND RESULTS. We reassessed risk prediction in the
10,219 survivors of myocardial infarction with follow-up data available
(ie, 98% of the total) who had been enrolled in the GISSI-2 trial, relying
on a set of prespecified variables. The 3.5% 6-month all-cause mortality
rate of these patients compared with the higher value of 4.6% found in the
corresponding GISSI- 1 cohort, originally allocated to streptokinase
therapy, indicates a 24% reduction in postdischarge 6-month mortality. On
multivariate analysis (Cox model), the following variables were predictors
of 6- month all-cause mortality: ineligibility for exercise test for both
cardiac (relative risk [RR], 3.30; 95% confidence interval [CI], 2.36-
4.62) and noncardiac reasons (RR, 3.28; 95% CI, 2.23-4.72), early left
ventricular failure (RR, 2.41; 95% CI, 1.87-3.09), echocardiographic
evidence of recovery phase left ventricular dysfunction (RR, 2.30; 95% CI,
1.78-2.98), advanced (more than 70 years) age (RR, 1.81; 95% CI,
1.43-2.30), electrical instability (ie, frequent and/or complex ventricular
arrhythmias) (RR, 1.70; 95% CI, 1.32-2.19), late left ventricular failure
(RR, 1.54; 95% CI, 1.17-2.03), previous myocardial infarction (RR, 1.47;
95% CI, 1.14-1.89), and a history of treated hypertension (RR, 1.32; 95%
CI, 1.05-1.65). Early post-myocardial infarction angina, a positive
exercise test, female sex, history of angina, history of insulin-dependent
diabetes, and anterior site of myocardial infarction were not risk
predictors. On further multivariate analysis, performed on 8315 patients
with the echocardiographic indicator of left ventricular dysfunction
available, only previous myocardial infarction was not retained as an
independent risk predictor. CONCLUSIONS. A decline in 6-month mortality of
myocardial infarction survivors, seen within 6 hours of symptom onset, has
been observed in recent years. Ineligibility for exercise test, early left
ventricular failure, and recovery-phase left ventricular dysfunction are
the most powerful (RR, > 2) predictors of 6-month mortality among
patients recovering from myocardial infarction after thrombolysis.
Qualitative variables reflecting residual myocardial ischemia do not appear
to be risk predictors. The lack of an independent adverse influence of
early post-myocardial infarction angina on 6-month survival represents a
major difference between this study and those of the prethrombolytic era.
ARTICLES
Determinants of 6-month mortality in survivors of myocardial infarction after thrombolysis. Results of the GISSI-2 data base. The Ad hoc Working Group of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-2 Data Base
GISSI Coordinating Center, Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy.
This article has been cited by other articles:
![]() |
A. B. Chicos, P. J. Kannankeril, A. H. Kadish, and J. J. Goldberger Parasympathetic effects on cardiac electrophysiology during exercise and recovery in patients with left ventricular dysfunction Am J Physiol Heart Circ Physiol, August 1, 2009; 297(2): H743 - H749. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Nicolosi, S. Golcea, C. Ceconi, G. Parrinello, A. Decarli, M. Chiariello, W. J. Remme, L. Tavazzi, R. Ferrari, and on behalf of the PREAMI Investigators Effects of perindopril on cardiac remodelling and prognostic value of pre-discharge quantitative echocardiographic parameters in elderly patients after acute myocardial infarction: the PREAMI echo sub-study Eur. Heart J., July 1, 2009; 30(13): 1656 - 1665. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Mizuno, S Fujimoto, Y Saito, and S Nakamura Depressed recovery of subendocardial perfusion in persistent heart failure after complete revascularisation in diabetic patients with hibernating myocardium Heart, May 1, 2009; 95(10): 830 - 834. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Crea, P. G. Camici, R. De Caterina, and G. A. Lanza CHAPTER 17 Chronic Ischaemic Heart Disease ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ishii, T. Amano, T. Matsubara, and T. Murohara Pharmacological Intervention for Prevention of Left Ventricular Remodeling and Improving Prognosis in Myocardial Infarction Circulation, December 16, 2008; 118(25): 2710 - 2718. [Full Text] [PDF] |
||||
![]() |
M. Kohler, J. C. T. Pepperell, B. Casadei, S. Craig, N. Crosthwaite, J. R. Stradling, and R. J. O. Davies CPAP and measures of cardiovascular risk in males with OSAS Eur. Respir. J., December 1, 2008; 32(6): 1488 - 1496. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Goldberger, M. E. Cain, S. H. Hohnloser, A. H. Kadish, B. P. Knight, M. S. Lauer, B. J. Maron, R. L. Page, R. S. Passman, D. Siscovick, et al. American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death: A Scientific Statement From the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention J. Am. Coll. Cardiol., September 30, 2008; 52(14): 1179 - 1199. [Full Text] [PDF] |
||||
![]() |
J. J. Goldberger, M. E. Cain, S. H. Hohnloser, A. H. Kadish, B. P. Knight, M. S. Lauer, B. J. Maron, R. L. Page, R. S. Passman, D. Siscovick, et al. American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death: A Scientific Statement From the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention Circulation, September 30, 2008; 118(14): 1497 - 1518. [Full Text] [PDF] |
||||
![]() |
T. W. Galema, M. L. Geleijnse, S.-C. Yap, R. T. van Domburg, E. Biagini, W. B. Vletter, and F. J. Ten Cate Assessment of left ventricular ejection fraction after myocardial infarction using contrast echocardiography Eur J Echocardiogr, March 1, 2008; 9(2): 250 - 254. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Dimmeler, J. Burchfield, and A. M. Zeiher Cell-Based Therapy of Myocardial Infarction Arterioscler Thromb Vasc Biol, February 1, 2008; 28(2): 208 - 216. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Blasko, R. Kolka, P. Thorbjornsdottir, S. T. Sigurtharson, G. Sigurthsson, Z. Ronai, M. Sasvari-Szekely, S. Bothvarsson, G. Thorgeirsson, Z. Prohaszka, et al. Low complement C4B gene copy number predicts short-term mortality after acute myocardial infarction Int. Immunol., January 1, 2008; 20(1): 31 - 37. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Jahangir, S. Sagar, and A. Terzic Aging and cardioprotection J Appl Physiol, December 1, 2007; 103(6): 2120 - 2128. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Radauceanu, F. Moulin, W. Djaballah, P. Y. Marie, F. Alla, B. Dousset, J. M. Virion, J. Capiaumont, G. Karcher, E. Aliot, et al. Residual stress ischaemia is associated with blood markers of myocardial structural remodelling Eur J Heart Fail, April 1, 2007; 9(4): 370 - 376. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Jassal, T. G. Neilan, A. D. Pradhan, K. E. Lynch, G. Vlahakes, A. K. Agnihotri, and M. H. Picard Surgical Management of Infective Endocarditis: Early Predictors of Short-Term Morbidity and Mortality Ann. Thorac. Surg., August 1, 2006; 82(2): 524 - 529. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Hernandez, E. J. Velazquez, S. D. Solomon, R. Kilaru, R. Diaz, C. M. O'Connor, G. Ertl, A. P. Maggioni, J.-L. Rouleau, W. van Gilst, et al. Left Ventricular Assessment in Myocardial Infarction: The VALIANT Registry Arch Intern Med, October 10, 2005; 165(18): 2162 - 2169. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pascale, P. Taffe, C. Regamey, L. Kappenberger, and M. Fromer Reduced Ejection Fraction After Myocardial Infarction: Is It Sufficient To Justify Implantation of a Defibrillator? Chest, October 1, 2005; 128(4): 2626 - 2632. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Hoffmann, S. von Bardeleben, F. ten Cate, A. C. Borges, J. Kasprzak, C. Firschke, S. Lafitte, N. Al-Saadi, S. Kuntz-Hehner, M. Engelhardt, et al. Assessment of systolic left ventricular function: a multi-centre comparison of cineventriculography, cardiac magnetic resonance imaging, unenhanced and contrast-enhanced echocardiography Eur. Heart J., March 2, 2005; 26(6): 607 - 616. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Desideri, P M Fioretti, L Cortigiani, G Trocino, C Astarita, D Gregori, J Bax, J Velasco, L Celegon, R Bigi, et al. Pre-discharge stress echocardiography and exercise ECG for risk stratification after uncomplicated acute myocardial infarction: results of the COSTAMI-II (cost of strategies after myocardial infarction) trial Heart, February 1, 2005; 91(2): 146 - 151. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Latini, A. P. Maggioni, G. Peri, L. Gonzini, D. Lucci, P. Mocarelli, L. Vago, F. Pasqualini, S. Signorini, D. Soldateschi, et al. Prognostic Significance of the Long Pentraxin PTX3 in Acute Myocardial Infarction Circulation, October 19, 2004; 110(16): 2349 - 2354. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Carrabba, R. Valenti, G. Parodi, G. M. Santoro, and D. Antoniucci Left Ventricular Remodeling and Heart Failure in Diabetic Patients Treated With Primary Angioplasty for Acute Myocardial Infarction Circulation, October 5, 2004; 110(14): 1974 - 1979. [Abstract] [Full Text] [PDF] |
||||
![]() |
J E Udelson and E J Flint Radionuclide imaging in risk assessment after acute coronary syndromes Heart, August 1, 2004; 90(suppl_5): v16 - v25. [Full Text] [PDF] |
||||
![]() |
R. Fincke, J. S. Hochman, A. M. Lowe, V. Menon, J. N. Slater, J. G. Webb, T. H. LeJemtel, G. Cotter, and SHOCK Investigators Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: A report from the SHOCK trial registry J. Am. Coll. Cardiol., July 21, 2004; 44(2): 340 - 348. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. Austin, D. A. Alter, and J. V. Tu The Use of Fixed-and Random-Effects Models for Classifying Hospitals as Mortality Outliers: A Monte Carlo Assessment Med Decis Making, November 1, 2003; 23(6): 526 - 539. [Abstract] [PDF] |
||||
![]() |
A. Desideri, P. M. Fioretti, L. Cortigiani, D. Gregori, C. Coletta, C. Vigna, F. Tota, R. Rambaldi, J. Bax, L. Celegon, et al. Cost of strategies after myocardial infarction (COSTAMI): A multicentre, international, randomized trial for cost-effective discharge after uncomplicated myocardial infarction Eur. Heart J., September 2, 2003; 24(18): 1630 - 1639. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Velazquez, M. A. Pfeffer, J. V. McMurray, A. P. Maggioni, J.-L. Rouleau, F. Van de Werf, L. Kober, H. D. White, K. Swedberg, J. D. Leimberger, et al. VALsartan In Acute myocardial iNfarcTion (VALIANT) trial: baseline characteristics in context Eur J Heart Fail, August 1, 2003; 5(4): 537 - 544. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Hasdai, E. I Lev, S. Behar, V. Boyko, N. Danchin, A. Vahanian, and A. Battler Acute coronary syndromes in patients with pre-existing moderate to severe valvular disease of the heart: lessons from the Euro-Heart Survey of acute coronary syndromes Eur. Heart J., April 1, 2003; 24(7): 623 - 629. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Picard, R. Davidoff, L. A. Sleeper, L. A. Mendes, C. R. Thompson, V. Dzavik, R. Steingart, K. Gin, H. D. White, J. S. Hochman, et al. Echocardiographic Predictors of Survival and Response to Early Revascularization in Cardiogenic Shock Circulation, January 21, 2003; 107(2): 279 - 284. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Nijland, O Kamp, P M J Verhorst, W G de Voogt, and C A Visser Early prediction of improvement in ejection fraction after acute myocardial infarction using low dose dobutamine echocardiography Heart, December 1, 2002; 88(6): 592 - 596. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Tyden, O Hansen, G Engstrom, B Hedblad, and L Janzon Myocardial infarction in an urban population: worse long term prognosis for patients from less affluent residential areas J Epidemiol Community Health, October 1, 2002; 56(10): 785 - 790. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.E. Otterstad, M.G. St. John Sutton, G.S. Froeland, I. Holme, T. Skjaerpe, and C. Hall Prognostic value of two-dimensional echocardiography and N-terminal proatrial natriuretic peptide following an acute myocardial infarction. Assessment of baseline values (2-7 days) and changes at 3 months in patients with a preserved systolic function Eur. Heart J., July 1, 2002; 23(13): 1011 - 1020. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Richards, M. G. Nicholls, R. W. Troughton, J. G. Lainchbury, J. Elliott, C. Frampton, E. A. Espiner, I. G. Crozier, T. G. Yandle, and J. Turner Antecedent hypertension and heart failure after myocardial infarction J. Am. Coll. Cardiol., April 3, 2002; 39(7): 1182 - 1188. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. Austin A Comparison of Bayesian Methods for Profiling Hospital Performance Med Decis Making, April 1, 2002; 22(2): 163 - 172. [Abstract] [PDF] |
||||
![]() |
P Andrassy, M Zielinska, R Busch, A Schomig, and C Firschke Myocardial blood volume and the amount of viable myocardium early after mechanical reperfusion of acute myocardial infarction: prospective study using venous contrast echocardiography Heart, April 1, 2002; 87(4): 350 - 355. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Sheifer, T. A. Manolio, and B. J. Gersh Unrecognized Myocardial Infarction Ann Intern Med, November 6, 2001; 135(9): 801 - 811. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Simon and H. Rosolova Predicting the coronary risk in primary and secondary prevention. What is the difference? Eur. Heart J., November 2, 2001; 22(22): 2047 - 2049. [PDF] |
||||
![]() |
R Marchioli, F Avanzini, F Barzi, C Chieffo, A Di Castelnuovo, M.G Franzosi, E Geraci, A.P Maggioni, R.M Marfisi, N Mininni, et al. Assessment of absolute risk of death after myocardial infarction by use of multiple-risk-factor assessment equations; GISSI-Prevenzione mortality risk chart Eur. Heart J., November 2, 2001; 22(22): 2085 - 2103. [Abstract] [PDF] |
||||
![]() |
M. del Mar de la Torre, J. A. San Roman, J. Bermejo, G. Pastor, J. Alonso, and F. Fernandez-Aviles Prognostic Power of Dobutamine Echocardiography After Uncomplicated Acute Myocardial Infarction in the Elderly Chest, October 1, 2001; 120(4): 1200 - 1205. [Abstract] [Full Text] [PDF] |
||||
![]() |
S H Poulsen, S E Jensen, J E Moller, and K Egstrup Prognostic value of left ventricular diastolic function and association with heart rate variability after a first acute myocardial infarction Heart, October 1, 2001; 86(4): 376 - 380. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Nicolau, C. V. Serrano Jr., S. A.C. Garzon, and J. A.F. Ramires Prognosis of acute myocardial infarction in the thrombolytic era: medical evaluation is still valuable Eur J Heart Fail, October 1, 2001; 3(5): 569 - 576. [Abstract] [Full Text] [PDF] |
||||
![]() |
G I W Galasko, S Basu, A Lahiri, and R Senior A prospective comparison of echocardiographic wall motion score index and radionuclide ejection fraction in predicting outcome following acute myocardial infarction Heart, September 1, 2001; 86(3): 271 - 276. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Abdulla, B Brendorp, C Torp-Pedersen, L Kober, and on behalf of the TRACE study group Does the electrocardiographic presence of Q waves influence the survival of patients with acute myocardial infarction? Eur. Heart J., June 2, 2001; 22(12): 1008 - 1014. [Abstract] [PDF] |
||||
![]() |
D. Scrutinio, C. Cimminiello, E. Marubini, M. Vittoria Pitzalis, M. Di Biase, P. Rizzon, and the STAMI Group Ticlopidine versus aspirin after myocardial infarction (stami) trial J. Am. Coll. Cardiol., April 1, 2001; 37(5): 1259 - 1265. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Bigi, A Desideri, A Galati, J J Bax, C Coletta, C Fiorentini, and P M Fioretti Incremental prognostic value of stress echocardiography as an adjunct to exercise electrocardiography after uncomplicated myocardial infarction Heart, April 1, 2001; 85(4): 417 - 423. [Abstract] [Full Text] |
||||
![]() |
G. Cerisano, L. Bolognese, P. Buonamici, R. Valenti, N. Carrabba, E. V. Dovellini, P. D. Pucci, G. M. Santoro, and D. Antoniucci Prognostic implications of restrictive left ventricular filling in reperfused anterior acute myocardial infarction J. Am. Coll. Cardiol., March 1, 2001; 37(3): 793 - 799. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Tavazzi Towards a more precise definition of heart failure aetiology Eur. Heart J., February 1, 2001; 22(3): 192 - 195. [PDF] |
||||
![]() |
H. Takano, X.-L. Tang, E. Kodani, and R. Bolli Late preconditioning enhances recovery of myocardial function after infarction in conscious rabbits Am J Physiol Heart Circ Physiol, November 1, 2000; 279(5): H2372 - H2381. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Morrow, E. M. Antman, A. Charlesworth, R. Cairns, S. A. Murphy, J. A. de Lemos, R. P. Giugliano, C. H. McCabe, and E. Braunwald TIMI Risk Score for ST-Elevation Myocardial Infarction: A Convenient, Bedside, Clinical Score for Risk Assessment at Presentation : An Intravenous nPA for Treatment of Infarcting Myocardium Early II Trial Substudy Circulation, October 24, 2000; 102(17): 2031 - 2037. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Lindahl, H. Toss, A. Siegbahn, P. Venge, L. Wallentin, and The FRISC Study Group Markers of Myocardial Damage and Inflammation in Relation to Long-Term Mortality in Unstable Coronary Artery Disease N. Engl. J. Med., October 19, 2000; 343(16): 1139 - 1147. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C GREAVES Assessment of left ventricular systolic function in research and in clinical practice Heart, May 1, 2000; 83(5): 493 - 494. [Full Text] |
||||
![]() |
S. H. Poulsen, N. B. Host, S. E. Jensen, and K. Egstrup Relationship Between Serum Amino-Terminal Propeptide of Type III Procollagen and Changes of Left Ventricular Function After Acute Myocardial Infarction Circulation, April 4, 2000; 101(13): 1527 - 1532. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.R. Conti Determining prognosis early after a myocardial infarction Eur. Heart J., April 2, 2000; 21(8): 609 - 610. [PDF] |
||||
![]() |
M. L. Chuang, M. G. Hibberd, C. J. Salton, R. A. Beaudin, M. F. Riley, R. A. Parker, P. S. Douglas, and W. J. Manning Importance of imaging method over imaging modality in noninvasive determination of left ventricular volumes and ejection fraction: Assessment by two- and three-dimensional echocardiography and magnetic resonance imaging J. Am. Coll. Cardiol., February 1, 2000; 35(2): 477 - 484. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Kim, R. M. Judd, E.-L. Chen, D. S. Fieno, T. B. Parrish, and J. A. C. Lima Relationship of Elevated 23Na Magnetic Resonance Image Intensity to Infarct Size After Acute Reperfused Myocardial Infarction Circulation, July 13, 1999; 100(2): 185 - 192. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. B. Ravn, U. Moeldrup, C. I. O. Brookes, L. B. Ilkjaer, P. White, M. Chew, L. Jensen, S. Johnsen, L. Birk-Soerensen, and V. E. Hjortdal Intravenous Magnesium Reduces Infarct Size After Ischemia/Reperfusion Injury Combined with a Thrombogenic Lesion in the Left Anterior Descending Artery Arterioscler Thromb Vasc Biol, March 1, 1999; 19(3): 569 - 574. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Picano, R. Sicari, P. Landi, L. Cortigiani, R. Bigi, C. Coletta, A. Galati, J. Heyman, R. Mattioli, M. Previtali, et al. Prognostic Value of Myocardial Viability in Medically Treated Patients With Global Left Ventricular Dysfunction Early After an Acute Uncomplicated Myocardial Infarction : A Dobutamine Stress Echocardiographic Study Circulation, September 15, 1998; 98(11): 1078 - 1084. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Previtali, R. Fetiveau, L. Lanzarini, C. Cavalotti, and C. Klersy Prognostic value of myocardial viability and ischemia detected by dobutamine stress echocardiography early after acute myocardial infarction treated with thrombolysis J. Am. Coll. Cardiol., August 1, 1998; 32(2): 380 - 386. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Baigent, R. Collins, P. Appleby, S. Parish, P. Sleight, and R. Peto ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither BMJ, May 2, 1998; 316(7141): 1337 - 1343. [Abstract] [Full Text] |
||||
![]() |
K. C. Wu, E. A. Zerhouni, R. M. Judd, C. H. Lugo-Olivieri, L. A. Barouch, S. P. Schulman, R. S. Blumenthal, and J. A. C. Lima Prognostic Significance of Microvascular Obstruction by Magnetic Resonance Imaging in Patients With Acute Myocardial Infarction Circulation, March 3, 1998; 97(8): 765 - 772. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Goodman, A. Langer, A. M. Ross, N. M. Wildermann, A. Barbagelata, E. B. Sgarbossa, G. S. Wagner, C. B. Granger, R. M. Califf, E. J. Topol, et al. Non–Q-Wave Versus Q-Wave Myocardial Infarction After Thrombolytic Therapy : Angiographic and Prognostic Insights From the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries–I Angiographic Substudy Circulation, February 10, 1998; 97(5): 444 - 450. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Malacrida, M. Genoni, A. P. Maggioni, V. Spataro, S. Parish, A. Palmer, R. Collins, T. Moccetti, and The Third International Study of Infarct Survival A Comparison of the Early Outcome of Acute Myocardial Infarction in Women and Men N. Engl. J. Med., January 1, 1998; 338(1): 8 - 14. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Sim, K. M. McDonald, P. W. Lavori, C. M. Norbutas, and M. A. Hlatky Quantitative Overview of Randomized Trials of Amiodarone to Prevent Sudden Cardiac Death Circulation, November 4, 1997; 96(9): 2823 - 2829. [Abstract] [Full Text] |
||||
![]() |
A. W. Haider, L. Chen, M. G. Larson, J. C. Evans, M. H. Chen, and D. Levy Antecedent Hypertension Confers Increased Risk for Adverse Outcomes After Initial Myocardial Infarction Hypertension, November 1, 1997; 30(5): 1020 - 1024. [Abstract] [Full Text] |
||||
![]() |
L. Tavazzi and A. Volpi Remarks About Postinfarction Prognosis in Light of the Experience With the Gruppo Italiano per lo Studio della Sopravvivenza nell' Infarto Miocardico (GISSI) Trials Circulation, March 4, 1997; 95(5): 1341 - 1345. [Full Text] |
||||
![]() |
R. S. Vasan and D. Levy The Role of Hypertension in the Pathogenesis of Heart Failure: A Clinical Mechanistic Overview Arch Intern Med, September 9, 1996; 156(16): 1789 - 1796. [Abstract] [PDF] |
||||
![]() |
G. Zuanetti, J. M.M. Neilson, R. Latini, E. Santoro, A. P. Maggioni, and D. J. Ewing Prognostic Significance of Heart Rate Variability in Post–Myocardial Infarction Patients in the Fibrinolytic Era: The GISSI-2 Results Circulation, August 1, 1996; 94(3): 432 - 436. [Abstract] [Full Text] |
||||
![]() |
K. L. Lee, L. H. Woodlief, E. J. Topol, W. D. Weaver, A. Betriu, J. Col, M. Simoons, P. Aylward, F. Van de Werf, and R. M. Califf Predictors of 30-Day Mortality in the Era of Reperfusion for Acute Myocardial Infarction : Results From an International Trial of 41 021 Patients Circulation, March 15, 1995; 91(6): 1659 - 1668. [Abstract] [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1993 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |